Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions
Remarks:
without GLP status

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1988
Report date:
1988

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
GLP compliance:
no
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
1-ethylpiperazine
EC Number:
226-166-6
EC Name:
1-ethylpiperazine
Cas Number:
5308-25-8
Molecular formula:
C6H14N2
IUPAC Name:
1-ethylpiperazine
Details on test material:
- Name of test material (as cited in study report): Ethylpiperazin, Partie 6, Abl.Nr. 64-6112
- Analytical purity: 98%
- PSN 88/0569

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Dr. Thomae, Biberach/Germany
- Weight at study initiation: 181 g (mean weight males), 180 g (mean weight females)
- Fasting period before study: 16 hours before administration, except water
- Housing: groups of 5
- Diet: Kliba Labordiaet, 343; ad libitum
- Water: tap water; ad libitum
- Acclimation period: at least 1 week

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 20, 10, 4.64 mg/ 100 mL
- Amount of vehicle (if gavage): 10 mL/kg
Doses:
464, 1000, 2000 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: Recording of signs and symptoms several times on the day of administration, at least once each workday. Check for moribund and dead animals twice each workday and once on holidays.
- Frequency of weighing: at day 0, 7 and 13 of the study
- Necropsy of survivors performed: yes

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
1 000 - 2 000 mg/kg bw
Based on:
test mat.
Remarks on result:
other: 4 male and 4 female animals of the 2000 mg/kg bw dose group died. Observed clinical signs were reversible within 14 days.
Mortality:
4 male and 4 female animals of the 2000 mg/kg bw dose group died during the first two days post treatment. No further mortality observed.
Clinical signs:
other: 2000 mg/kg bw dose group: Dyspnea, apathy, staggering, piloerection and poor general state was observed post treatment (4 hours) and up to 2 days after treatment in all animals. Twitching was observed 4 hours after treatment in the female animals. Afterwa
Gross pathology:
Animals that died (male + female): General congestion.
Stomach: atonic; reddened mucosa; striking liquid contents.
Intestines: atonic; reddened mucosa; liquid contents, in most animal bloody.
No pathological findings noted in surviving animals.

Applicant's summary and conclusion

Interpretation of results:
Category 4 based on GHS criteria